Syneron Medical Ltd. (NASDAQ: ELOS), an innovator in the development, marketing and sales of elos(TM) combined-energy medical aesthetic devices, today announces its Vela(TM) platform has received the US Food and Drug Administration (FDA) 510(k) pre-marketing clearance and CE Mark certification in the European Union for the temporary reduction of thigh circumference. This announcement marks the first FDA clearance and CE Mark certificationn for a product designed to reduce circumferences in the body.
The Syneron Vela platform previously received clearance by the FDA for cellulite treatment. This new clearance enhances Syneron's leading position in the fast-growing global market of non-invasive body shaping and contouring.
Hat Tip: Medgadget